Abstract:Background: The ability to predict Alzheimers disease (AD) before diagnosis is a topic of intense research. Early diagnosis would aid in improving treatment and intervention options, however, there are no current methods that can accurately predict AD years in advance. This study examines a novel machine learning approach that integrates the combined effects of vascular (white matter hyperintensities, WMHs), and structural brain changes (gray matter, GM) with clinical factors (cognitive status) to predict post-mortem neuropathological outcomes. Methods: Healthy older adults, participants with mild cognitive impairment, and AD from the Alzheimer's Disease Neuroimaging Initiative dataset with both post-mortem neuropathology data and antemortem MRI and clinical data were included. Longitudinal data were analyzed across three intervals before death (post-mortem data): 0-4 years, 4-8 years, and 8-14 years. Additionally, cross-sectional data at the last visit or interval (within four years, 0-4 years) before death were also examined. Machine learning models including gradient boosting, bagging, support vector regression, and linear regression were implemented. These models were applied towards feature selection of the top seven MRI, clinical, and demographic data to identify the best performing set of variables that could predict postmortem neuropathology outcomes (i.e., neurofibrillary tangles, neuritic plaques, diffuse plaques, senile/amyloid plaques, and amyloid angiopathy). Results: A total of 94 participants (55-90 years of age) were included in the study. At last visit, the best-performing model included total and temporal lobe WMHs and achieved r=0.87(RMSE=0.62) during cross-validation for neuritic plaques. For longitudinal assessments across different intervals, the best-performing model included regional GM (i.e., hippocampus, amygdala, caudate) and frontal lobe WMH and achieved r=0.93(RMSE=0.59) during cross-validation for neurofibrillary tangles. For MRI and clinical predictors and clinical-only predictors, t-tests demonstrated significant differences at all intervals before death (t[-13.60-7.90], p-values<0.001). Overall, post-mortem neuropathology outcome were predicted up to 14 years before death with high accuracies (~90%). Conclusions: Prediction accuracy was higher for post-mortem neuropathology outcomes that included MRI (WMHs, GM) and clinical features compared to clinical-only features. These findings highlight that MRI features are critical to successfully predict AD-related pathology years in advance which will improve participant selection for clinical trials, treatments, and intervention options.

The role of artificial intelligence and machine learning in harmonization of high-resolution post-mortem MRI (virtopsy) with respect to brain microstructure

Automated deep learning segmentation of high-resolution 7 T postmortem MRI for quantitative analysis of structure-pathology correlations in neurodegenerative diseases

Automated deep learning segmentation of high-resolution 7 Tesla postmortem MRI for quantitative analysis of structure-pathology correlations in neurodegenerative diseases

Postmortem 7T MRI for guided histopathology and evaluation of cerebrovascular disease

Statistical analysis to identify MRI markers for Alzheimer’s Disease: why moving towards AI?

Magnetic Resonance Imaging Studies of Neurodegenerative Disease: from Methods to Translational Research

IMAGING MICROSCOPIC NEUROPATHOLOGY OF ALZHEIMER’S DISEASE USING MRI: FROM MODEL SYSTEMS TO HUMAN IN VIVO

Exploring the power of MRI and clinical measures in predicting Alzheimers disease neuropathology

Surface-based parcellation and vertex-wise analysis of ultra high-resolution ex vivo 7 tesla MRI in Alzheimer's disease and related dementias

Exploring the Feasibility of Integrating Ultra‐high Field Magnetic Resonance Imaging Neuroimaging with Multimodal Artificial Intelligence for Clinical Diagnostics

Unveiling the future: Advancements in MRI imaging for neurodegenerative disorders

Comparative analysis of in situ and ex situ postmortem brain MRI: Evaluating volumetry, DTI, and relaxometry

Artificial Intelligence-Based Methodologies for Early Diagnostic Precision and Personalized Therapeutic Strategies in Neuro-Ophthalmic and Neurodegenerative Pathologies

3D Reconstruction and Segmentation of Dissection Photographs for MRI-free Neuropathology

Machine learning of dissection photographs and surface scanning for quantitative 3D neuropathology

The artificial intelligence in autopsy and crime scene analysis

Advances in neuroimaging to support translational medicine in dementia

Virtual Mouse Brain Histology from Multi-contrast MRI Via Deep Learning

Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review

A tool to automate assessment of regional brain atrophy in mouse models of neurodegenerative disease